Real-world individual and comparative analysis of adverse event reporting for adalimumab and etanercept using public FDA adverse event reporting system data
Archives of Dermatological Research · 2024
DOI: 10.1007/s00403-024-03626-5 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Archives of Dermatological Research, 2024. Verfasst von Xiaoke Dou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. Hauptthemen laut MEDLINE: Adalimumab, Etanercept, Adverse Drug Reaction Reporting Systems, United States Food and Drug Administration. Die Arbeit nennt 57 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
- Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
- Key Laboratory of Anesthesiology and Resuscitation, Huazhong University of Science and Technology, Ministry of Education, Wuhan, China.
- Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277, Jiefang Avenue, Wuhan, 430022, China.
- Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277, Jiefang Avenue, Wuhan, 430022, China. wuyan5151@hust.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Dou, X., Dai, Y., Zhu, L., Lin, Y., & Wu, Y. (2024). Real-world individual and comparative analysis of adverse event reporting for adalimumab and etanercept using public FDA adverse event reporting system data. Archives of Dermatological Research. https://doi.org/10.1007/s00403-024-03626-5
Vancouver
Dou X, Dai Y, Zhu L, Lin Y, Wu Y. Real-world individual and comparative analysis of adverse event reporting for adalimumab and etanercept using public FDA adverse event reporting system data. Archives of Dermatological Research. 2024. doi:10.1007/s00403-024-03626-5
BibTeX
@article{Dou2024,
author = {Dou, Xiaoke and Dai, Yan and Zhu, Li and Lin, Yun and Wu, Yan},
title = {Real-world individual and comparative analysis of adverse event reporting for adalimumab and etanercept using public FDA adverse event reporting system data},
journal = {Archives of Dermatological Research},
year = {2024},
doi = {10.1007/s00403-024-03626-5}
}
EUVIMED